Insider · CIK 0001378251
Shami Patel
Files at CERO (CERO THERAPEUTICS HOLDINGS, INC.). First filing -, latest -.
Shami Patel files SEC Form 4 as director at CERO (CERO THERAPEUTICS HOLDINGS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Shami Patel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +690,900 | $0.00 | $0 | 690,900 | Jan 9, 2026 |
| May 30, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +11,693 | $0.00 | $0 | 11,693 | Jun 2, 2025 |
| Mar 4, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +14,936 | $0.00 | $0 | 14,936 | Mar 6, 2025 |
| Feb 24, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +127,500 | $0.00 | $0 | 255,000 | Feb 26, 2025 |
| Dec 2, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +127,500 | $0.00 | $0 | 127,500 | Dec 4, 2024 |
Questions about Shami Patel
Answered from the filings on this page, as of the latest one.
Is Shami Patel buying or selling?
Shami Patel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Shami Patel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Shami Patel has 0.
Where does Shami Patel file Form 4?
Shami Patel has filed Form 4 at CERO (CERO THERAPEUTICS HOLDINGS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.